We received 33 proposals in response to IHI calls 1 (18 proposals) & 2 (15 proposals). The next steps are the eligibility check, and then eligible proposals will be evaluated by independent experts.
A farewell reflection on research and innovation in the 21st century
On 15 September, Pierre Meulien’s term as IMI/IHI Executive Director drew to a close. In a final opinion piece, he reflects on the ongoing influence of IMI and IHI on the research and innovation process.
Battling drug-resistant tuberculosis: New life for old treatments
A new compound that boosts the efficacy of the tuberculosis drug ethianomide has successfully completed phase 1 clinical trials, thanks to IMI project TRIC-TB.
IMI project H2O has launched its first health outcomes observatories, in the Netherlands, Spain and Austria. The observatories cover cancer, diabetes, and inflammatory bowel disease.
